SKI Market

Indian Indices

Nifty

24,718.60 -169.60
(-0.68%)

Sensex

81,803.71 685.11
( 0.84%)

Bank Nifty

55,527.35 -555.20
( -0.99%)

Nifty IT

38,469.25 8.95
( 0.02%)

Global Indices

Nasdaq

42,214.73 -773.90
(-1.80%)

Dow Jones

5,997.34 -68.92
(-1.14%)

Hang Seng

38,275.58 441.33
(1.17%)

Nikkei 225

8,850.63 -34.29
(-0.39%)

Forex

USD-INR

85.55 0.07
(0.08%)

EUR-INR

98.89 0.98
(1.00%)

GBP-INR

116.24 0.70
(0.61%)

JPY-INR

0.60 0.01
(0.86%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambalal Sarabhai Enterprises Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500009

INE432A01017

6.3279669

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBASARABH

36.36

278.64

EPS(TTM)

Face Value()

Div & Yield %

Back

escorp asset management ltd

Stellant Securities (India) standalone net profit declines 62.96% in the December 2024 quarter

Jan 31,2025

Net profit of Stellant Securities (India) declined 62.96% to Rs 0.10 crore in the quarter ended December 2024 as against Rs 0.27 crore during the previous quarter ended December 2023. Sales declined 53.13% to Rs 0.15 crore in the quarter ended December 2024 as against Rs 0.32 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0.15	0.32	-53
OPM %	93.33	84.38	-
PBDT	0.14	0.27	-48
PBT	0.14	0.27	-48
NP	0.10	0.27	-63

24,718.60 -169.60 (-0.68%)

81,803.71 685.11 ( 0.84%)

55,527.35 -555.20 ( -0.99%)

38,469.25 8.95 ( 0.02%)

42,214.73 -773.90 (-1.80%)

5,997.34 -68.92 (-1.14%)

38,275.58 441.33 (1.17%)

8,850.63 -34.29 (-0.39%)

85.55 0.07 (0.08%)

98.89 0.98 (1.00%)

116.24 0.70 (0.61%)

0.60 0.01 (0.86%)